companies > R > Ranbaxy Ranbaxy AEGON Religare Life Insurance gets IRDA approval 30 June 2008 Tentative nod from USFDA for Ranbaxy's cancer drug valganciclovir 26 June 2008 LIC may offload Ranbaxy stake as it rejigs investment portfolio 19 June 2008 Pfizer and Ranbaxy settle global Lipitor patent litigation 18 June 2008 Daiichi to make open offer for Ranbaxy on August 8 16 June 2008 Report on Pfizer move buoys Ranbaxy stock to a 3-year high 13 June 2008 Behind the Ranbaxy sale 12 June 2008 This is the start of a much larger game 11 June 2008 Ranbaxy gets partial relief in `atorvastatin' case in Australia 28 May 2008 Ranbaxy's Religare completes 97-per cent acquisition of UK broking firm Hichens for £56 million 27 May 2008 Ranbaxy's Malvinder Singh among pharma's most influential Indians 19 May 2008 Ranbaxy to develop new drugs for Merck & Co 10 May 2008 Ranbaxy gets a boost as US patent office rejects Pfizer's Liptor plea 28 April 2008 Ranbaxy forces Orchid into an alliance 22 April 2008 Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US 15 April 2008 Why Ranbaxy fancies Orchid 14 April 2008 Ranbaxy group closer to 15 per cent stake in Orchid 14 April 2008 Ranbaxy's Solrex picks up 1 per cent more in Orchid Chemicals 11 April 2008 Orchid Chemicals stock surges as Ranbaxy group hikes stake 08 April 2008 Ranbaxy receives Japanese authorisation for product development outside Japan 08 April 2008 Ranbaxy introduces world's first biogeneric injectible drug for osteoporosis 03 April 2008 Ranbaxy's Religare becomes first Indian brokerage to acquire London firm 26 March 2008 Ranbaxy to introduce dental drug Inersan in India, Nepal 18 March 2008 SC refuses to stay Gujarat HC order on Ranbaxy's 'Volini' ad 12 March 2008 Ranbaxy board approves de-merger of new drug discovery research unit in to Ranbaxy Life Science Research Ltd 19 February 2008 USFDA grants tentative approval to Ranbaxy's esomeprazole magnesium DR capsules in the US 07 February 2008 US FDA approves Ranbaxy's generic version of GlaxoSmithKline's Ceftin for US sales 06 February 2008 Ranbaxy announces settlement of possible Imitrex litigation with Glaxosmithkline 21 January 2008 Ranbaxy enters Chyawanprash market with suger-free `Chyawan Active' 11 January 2008 Ranbaxy wins patent case against Pfizer cholestrol drug Liptor in Germany 30 October 2007 Ranbaxy launches Osonase nasal spray in India 25 October 2007 Ranbaxy follows Sun Pharma in demerging R&D business 19 October 2007 Ranbaxy plans to spin off research arm as Q3 net profit zooms 48 per cent 18 October 2007 Ranbaxy to raise stake in Zenotech Laboratories 13 October 2007 Zenotech to boost Ranbaxy''s presence in generic biopharmaceuticals 09 October 2007 Ranbaxy to up Zenotech Lab stake to 45 per cent for Rs214 crore 03 October 2007 Ranbaxy enters in-licensing agreement with Sirtex Medical to market SIR-Spheres for liver cancer 24 September 2007 Ranbaxy receives WHO pre-qualification for three more ARVS 15 September 2007 Ranbaxy launches urology drug Roliflo OD based on multiparticulate technology 14 September 2007 Ranbaxy wins Lipitor case in Canadian Federal Court; Pfizer''s application on atorvastatin dismissed 13 September 2007 Ipca-Ranbaxy alliance to market Metformin HCL tablets in US 14 August 2007 Ranbaxy to sell authorised generics product Isoptin SR in US 30 July 2007 Ranbaxy, GSK to settle valacyclovir patent case in US 26 July 2007 Significant opportunities for Ranbaxy from GlaxoSmithKline deal: Malvinder Singh 26 July 2007 Ranbaxy to benefit from 180-day US market exclusivity for its pravastatin 25 June 2007 Ranbaxy buys 13 dermatology brands from Bristol-Myers 28 May 2007 US FDA approves Ranbaxy''s pravastatin sodium tablets 25 April 2007 Ranbaxy Labs acquires 14.9-per cent stake in Jupiter Bio Science 07 April 2007 Terapia Ranbaxy receives 3-year GMP certification renewal for Bucharest facility 04 April 2007 Ranbaxy-GSK alliance to develop respiratory drug 02 April 2007 Ranbaxy launches asthma drug 'Osovair' in India 30 March 2007 Ranbaxy withdraws bid for Merck's generic business 20 March 2007 Ranbaxy enters second round of bidding for Merck unit: report 16 March 2007 Ranbaxy gets USFDA nod for zolpidem tablet production in US 16 March 2007 Ranbaxy Laboratories Bids for Merck''s Generic Unit 13 March 2007 US firm acquires global rights for anti-cholestrol drug from Ranbaxy 01 March 2007 Ranbaxy plans ADS offering to finance Merck arm acquisition 21 February 2007 Ranbaxy enters biosimilar product space with Zenotech, targets EU markets 08 February 2007 Ranbaxy-Glaxo extend pact 07 February 2007 Glaxo moves court against Ranbaxy''s generic drug 03 February 2007 Ranbaxy launches two NDDS Urology products in India 30 January 2007 Ranbaxy pitted against Texas Pacific, Cinven, Permira for Merck''s generic-drug unit 12 January 2007 Ranbaxy to bid over $5 billion for Merck Generics 09 January 2007 Ipca - Ranbaxy alliance receive US FDA marketing approval for atenolol tablets 02 January 2007 Ranbaxy wins Lipitor patent against Pfizer in Australia 21 December 2006 Ranbaxy, department of science and technology to jointly develop new drugs 18 December 2006 Ranbaxy gets USFDA approval for Cefprozil anti-infective tablets 15 December 2006 Ranbaxy acquires South Africa's fifth largest generics company 01 December 2006 US Court''s Zocor verdict to benefit Ranbaxy and Dr Reddy''s 15 November 2006 Ranbaxy to introduce Debiopharm's gastro drug in India 23 October 2006 US FDA approves Ranbaxy's sale of furosemide in the US 21 September 2006 Ranbaxy to market Ethypharm's cardiovascular drug in India 18 September 2006 Fortis emerges a winner in Delhi''s pvt healthcare sector 13 September 2006 Ranbaxy receives US FDA nod to market loperamide hydrochloride and simethicone tablets 11 September 2006 Ranbaxy wins two additional atorvastatin patents in Norway 30 August 2006 Ranbaxy receives tentative US FDA approval to market Risperidone oral solution 05 August 2006 Mixed victory for Ranbaxy in patent row with Pfizer 03 August 2006 Ranbaxy Q2 global sales up 7 per cent at $317 million; net vaults 20 per cent 20 July 2006 Ranbaxy acquires GlaxoSmithKline subsidiary Mundogen in Spain 18 July 2006 Ranbaxy's 'Cefprozil' gets US FDA approval 01 July 2006 U K appeals court affirms HC ruling in Ranbaxy-Pfizer case 28 June 2006 Ranbaxy gains WHO pre-qualification for four more ARVs 24 May 2006 Ranbaxy reports steady Q1 numbers; helped by strong domestic sales 20 April 2006 CRISIL reaffirms rating of RANBAXY LABORATORIES following acquisition announcement 04 April 2006 Triple strike : Ranbaxy in third European acquisition in three days 31 March 2006 Ranbaxy acquires Romanian drug firm for $324 million 29 March 2006 Ranbaxy to acquire Glaxo's generic business in Italy 28 March 2006 Ranbaxy acquires patent & rights for auto-injector device 21 March 2006 Ranbaxy Laboratories ties-up with Zenotech to market cancer injectibles 09 March 2006 Setback for Ranbaxy; Finnish court reverses earlier verdict on Lipitor 22 February 2006 Dr Reddy's beats Ranbaxy; snaps up Betapharm for €480 million 16 February 2006 Ranbaxy raises $400 million from FCCB issue 16 February 2006 Ranbaxy forms South African JV to sell AIDS drug 06 February 2006 Dr Reddy's, Ranbaxy lead race to acquire 3i's stake in Betapharm 03 February 2006 Ranbaxy in co-marketing agreement with Ferring of Switzerland 10 January 2006 Ranbaxy, Cephalon to settle Provigil patent litigation 22 December 2005 Ranbaxy to appeal US District Court decision upholding Pfizer Atorvastatin Patents 19 December 2005 Ranbaxy offers to help U S combat avian flu 02 December 2005 Ranbaxy honours scientists for outstanding research 28 November 2005 US Court of Appeals upholds preliminary injunction against Ranbaxy 23 November 2005 AstraZeneca sues Ranbaxy on Nexium patent 22 November 2005 Ranbaxy scores over Pfizer in Norwegian court over cholesterol drug 10 November 2005 CRISIL reaffirms Ranbaxy''s outstanding ratings despite court ruling 15 October 2005 Ranbaxy obtains US FDA approval for high BP drug 14 September 2005 Ranbaxy, JB Chem to market Doktor Mom brand in Romania 06 July 2005 Maharashtra FDA questions claims of nutraceuticals 28 June 2005 USFDA gives tentative nod for Ranbaxy drug 01 June 2005 The rest didn''t do badly, either 16 February 2005 Ranbaxy makes three fresh ARV filings to WHO 25 January 2005 Ranbaxy Top brass reshuffled 22 January 2005 Ranbaxy Q4 results disappoints 19 January 2005 Ranbaxy withdraws its antiretroviral''s from WHO list 10 November 2004 Fortis to invest over Rs1,100 crore in integrated healthcare delivery system 17 August 2004 Ranbaxy net down six per cent 02 August 2004 Ranbaxy in pact for new drug discovery 30 April 2004 Ranbaxy crosses the billion dollar mark 11 March 2004 Ranbaxy enters the field of herbal medicine 22 January 2004 USFDA approval for Ranbaxy drug 10 January 2004 Retreat of a titan 29 December 2003 Ranbaxy''s first round of talks to acquire RPG Life Sciences over 05 December 2003 WHO declares pre-qualification of Ranbaxy''s Triviro-LNS tablets 04 December 2003 Ranbaxy to invest Rs 120 crore for R&D in Andhra Pradesh 22 September 2003 FIIs, banks up holdings in Ranbaxy, Dr Reddy''s, Nicholas Piramal, Cipla 21 July 2003 Ranbaxy, MMV Geneva in R&D tie-up for anti-malarial drug 19 May 2003 Ranbaxy to provide AIDS drugs to 10 lakh patients 29 November 2002 Ranbaxy Laboratories clocks Rs 1,594-million Q2 net profit 18 October 2002 Ranbaxy secures 10% stake in Nihon Pharma 26 September 2002 Ranbaxy gets USFDA approval for Terazosin 26 September 2002 Ranbaxy refutes Glaxo’s charge of stealing 24 August 2002 Glaxo SmithKline to sue Novartis, Ranbaxy 23 August 2002 Ranbaxy acquires Signature Pharma facility 23 July 2002 Ranbaxys new chemical entity gets license 27 June 2002 Ranbaxy Labs wants to buy out SRL 14 February 2002 Ranbaxy joins hands with NIPER 10 January 2002 Pharma sector fared well in 2001 28 December 2001 Sildenafil citrate drug sales surge 05 December 2001 The future is bright for pharma firms 21 November 2001 Ranbaxy Fine Chemicals Ltd 01 March 2000 Ranbaxy to sell ranitidine 75mg tablets in the US 13 January 2000 Ranbaxy closes $65 million Bayer deal 09 September 1999 Ranbaxy to raise research spending to 6 per cent of sales by 2002 09 September 1999 Ode to a visionary 04 July 1999 Hoechst, Nicholas Piramal to co-market two products 01 July 1999 Ranbaxy in talks with Bayer for licensing ciprofloxacin delivery system 25 June 1999 Ranbaxy pushes Pravosin to phase-1 trials 30 May 1999 Ajanta, Ranbaxy plan co-marketing 27 April 1999  search domain-b    go
Legal Policy | Copyright © 1999-2008 The Information Company Private Limited. All rights reserved.